| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/25/2002 | WO2002057454A2 Receptors and membrane-associated proteins |
| 07/25/2002 | WO2002057453A2 Polypetides and nucleic acids encoding same |
| 07/25/2002 | WO2002057452A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | WO2002057427A2 Mammalian tumor susceptibility gene products and their uses |
| 07/25/2002 | WO2002057413A2 Peptides for activation and inhibition of delta pkc |
| 07/25/2002 | WO2002057309A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/25/2002 | WO2002057298A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | WO2002057271A2 Thienopyrimidine-based inhibitors of the src family |
| 07/25/2002 | WO2002057267A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 07/25/2002 | WO2002057265A1 Compounds substituted with bicyclic amino groups |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002057257A1 Cyclo`c!azepane derivatives which are used as farnesyltransferase inhibitors and method for the preparation therefor |
| 07/25/2002 | WO2002057256A1 Piperazinylcarbonylquinolines and -isoquinolines |
| 07/25/2002 | WO2002057253A2 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders |
| 07/25/2002 | WO2002057252A2 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 07/25/2002 | WO2002057250A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 07/25/2002 | WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | WO2002057230A1 Il-8 receptor antagonists |
| 07/25/2002 | WO2002057226A2 68730 and 69112 protein kinase molecules and uses therefor |
| 07/25/2002 | WO2002057222A2 Thiol-based naaladase inhibitors |
| 07/25/2002 | WO2002057218A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 07/25/2002 | WO2002057215A2 Sodium channel modulators |
| 07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | WO2002056964A1 Use of flumazenil in developing a drug for the treatment of alcohol dependence |
| 07/25/2002 | WO2002056916A2 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients |
| 07/25/2002 | WO2002056915A2 Complex of modafinil and cyclodextrin |
| 07/25/2002 | WO2002056910A1 Binding domain-immunoglobulin fusion proteins |
| 07/25/2002 | WO2002056907A2 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | WO2002056905A2 Molecular antigen array |
| 07/25/2002 | WO2002056894A1 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 07/25/2002 | WO2002056892A2 Methods of treating neurological disorders |
| 07/25/2002 | WO2002056878A2 Pharmaceutical composition having reduced tendency for drug crystallization |
| 07/25/2002 | WO2002056877A1 Treatment of sleep disturbances |
| 07/25/2002 | WO2002056875A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | WO2002056870A2 Method for treating sleep disorders |
| 07/25/2002 | WO2002056869A2 Method for treating sexual disorders |
| 07/25/2002 | WO2002056868A2 Method for treating stress or tension |
| 07/25/2002 | WO2002056827A2 Substituted felbamate derived compounds |
| 07/25/2002 | WO2002056745A2 Method of treating parkinson's disease |
| 07/25/2002 | WO2002039988A3 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 07/25/2002 | WO2002039879A3 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 07/25/2002 | WO2002036071A3 Method of treating and preventing migraine headaches |
| 07/25/2002 | WO2002032901A3 Bridged piperazine derivatives |
| 07/25/2002 | WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002018379A3 7-oxo pyridopyrimidines |
| 07/25/2002 | WO2002015886A3 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 07/25/2002 | WO2002012461A3 Regulation of human membrane-type serine protease |
| 07/25/2002 | WO2002006306A3 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 07/25/2002 | WO2002005849A3 Transportation of nucleic acid substances |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001093865A3 Medicaments for treating dementia |
| 07/25/2002 | WO2001090091A8 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/25/2002 | WO2001088126A3 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR |
| 07/25/2002 | WO2001085940A3 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS |
| 07/25/2002 | WO2001082919B1 Methods of and compounds for inhibiting calpains |
| 07/25/2002 | WO2001070222A3 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 07/25/2002 | WO2001034201A9 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 07/25/2002 | WO2001004157A9 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | WO2001000812A9 22012, a novel human carboxypeptidase |
| 07/25/2002 | WO2001000665A9 Inhibitors of memapsin 2 and use thereof |
| 07/25/2002 | US20020099222 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 07/25/2002 | US20020099216 Compounds useful in therapy |
| 07/25/2002 | US20020099207 Has activity as an antagonist to neurokinin 1 receptors; for therapy of benign prostatic hyperplasia (BPH) |
| 07/25/2002 | US20020099191 EDG8 receptor, its preparation and use |
| 07/25/2002 | US20020099098 Method for treating sexual disorders |
| 07/25/2002 | US20020099097 Pharmaceutical solutions of modafinil compounds |
| 07/25/2002 | US20020099092 For therapy of neurological conditions, e.g. epilepsy and pain |
| 07/25/2002 | US20020099076 Dementias include alzheimer's disease, Lewy Body Dementia, Vascular Dementia, Dementia in Parkinson's Disease, Fronto-Temporal Dementia, Pick's Disease and Corticobasal Degeneration |
| 07/25/2002 | US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
| 07/25/2002 | US20020099068 I kappa B kinase inhibitors for treating various disorders including arthritis |
| 07/25/2002 | US20020099064 Analgesic combination of oxycodone and T-614 |
| 07/25/2002 | US20020099061 5-amino-pyrazolo-(4, 3-e)-1,2,4-triazolo(1,5-c)pyrimidine adenosine A2a receptor antagonists; use in the treatment of central nervous system diseases, in particular Parkinson's disease |
| 07/25/2002 | US20020099049 Analgesic combination of oxycodone and meloxicam |
| 07/25/2002 | US20020099048 Bicycloloactam compounds, use thereof and intermediates for preparing thereof |
| 07/25/2002 | US20020099045 Administering a sigma receptor ligand in combination with an antidepressant agent; especially for refractory depression |
| 07/25/2002 | US20020099010 Neurogenic compositions and methods |
| 07/25/2002 | US20020099008 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor |
| 07/25/2002 | US20020098550 Nucleotide sequences coding membrane protein for use in treatment and prevention of endotoxin shock, viral disease, immflammation and tumors |
| 07/25/2002 | US20020098240 Compositions comprising modafinil compounds |
| 07/25/2002 | US20020098237 Neurotoxin implant |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098195 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 07/25/2002 | US20020098173 Amyloid modulators of an A beta aggregation core domain and a modifying group coupled to it |
| 07/25/2002 | US20020098161 Therapeutic polyanhydride compounds for drug delivery |
| 07/25/2002 | DE19983487C1 Verfahren zur Herstellung von Citalopram A process for the preparation of citalopram |
| 07/25/2002 | DE10112829C1 Verfahren zur Herstellung von gereinigtem Citalopram A method for preparing purified citalopram |
| 07/25/2002 | DE10102944A1 Production of 3-cyano-1H-indol-7-yl)-(4-(4-fluorophenethyl)piperazin-1-yl)-methanone useful as a selective 5-HT2A antagonist comprises use of an indolecarboxylic acid ester as the starting material |
| 07/25/2002 | DE10056059A1 Differenzierung auslösende Substanzen Differentiation-inducing substances |
| 07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
| 07/25/2002 | CA2434939A1 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | CA2434866A1 Screening assay for cotranslational translocation interfering compounds |
| 07/25/2002 | CA2434736A1 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | CA2434338A1 Pharmaceutical composition having reduced tendency for drug crystallization |
| 07/25/2002 | CA2433879A1 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | CA2433862A1 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | CA2433835A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 07/25/2002 | CA2433316A1 Molecular antigen array |